Sclerotherapy is a minimally invasive procedure performed by a healthcare provider to treat uncomplicated spider veins and uncomplicated reticular veins. It involves an injection of a solution (sclerosis agent) into the affected veins. It has been used since 1939.
A typical sclerotherapy session lasts 15 to 45 minutes. More than one treatment may be necessary to clinically treat superficial veins 3mm or less in diameter. 2-3 treatments separated 4-6 weeks are usually needed for desired results.
Sclerotherapy is contraindicated on patients who have the following:
Known Allergy (anaphylaxis) to polidocanol and patients with acute thromboembolic disease
Severe circulatory problems such as cellulitis